NDC 72865-144 – Lamivudine And Zidovudine

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC72865-144

Product details

Brand name
Lamivudine And Zidovudine
Generic name
Lamivudine and zidovudine
Labeler
XLCare Pharmaceuticals, Inc
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203259
Marketed since
April 17, 2020
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (1)

Package NDCDescriptionSince
72865-144-6060 TABLET, FILM COATED in 1 BOTTLE (72865-144-60)Apr 17, 2020

Other LAMIVUDINE and ZIDOVUDINE products